These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16522134)
1. Modeling the impact of antiretroviral use in developing countries. Bertozzi SM; Bautista-Arredondo S PLoS Med; 2006 Apr; 3(4):e148. PubMed ID: 16522134 [TBL] [Abstract][Full Text] [Related]
2. Designing an equitable strategy for allocating antiretroviral treatments. Capron AM; Reis A PLoS Med; 2005 Mar; 2(3):e69. PubMed ID: 15737013 [TBL] [Abstract][Full Text] [Related]
3. The real challenges for scaling up ART in sub-Saharan Africa. Van Damme W; Kober K; Laga M AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294 [No Abstract] [Full Text] [Related]
4. Modelling the impact of antiretroviral use in resource-poor settings. Baggaley RF; Garnett GP; Ferguson NM PLoS Med; 2006 Apr; 3(4):e124. PubMed ID: 16519553 [TBL] [Abstract][Full Text] [Related]
5. Combining evidence for access to and benefits from antiretroviral treatment to inform planning. ; Marlink R; Forsythe S; Bertozzi SM; Muirhead D; Holmes M; Sturchio J AIDS; 2008 Jul; 22 Suppl 1():S121-2. PubMed ID: 18664943 [No Abstract] [Full Text] [Related]
6. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'. Hastings IM; Lalloo DG; Khoo SH AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825 [No Abstract] [Full Text] [Related]
7. HIV drug resistance. Calmy A; Pascual F; Ford N N Engl J Med; 2004 Jun; 350(26):2720-1. PubMed ID: 15215494 [No Abstract] [Full Text] [Related]
8. Call for action to secure universal access to ART in developing countries. Orsi F; Carrieri MP; Coriat B; Delaporte E; Moatti JP; Spire B; Taverne B; Barré-Sinoussi F Lancet; 2010 May; 375(9727):1693-4. PubMed ID: 20472168 [No Abstract] [Full Text] [Related]
9. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up. Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311 [No Abstract] [Full Text] [Related]
10. Will ART rollout in Africa drive an epidemic of drug resistant HIV? Hastings IM; Lalloo D; Khoo SH AIDS; 2006 Jun; 20(9):1354-6; author reply 1356-7. PubMed ID: 16816578 [No Abstract] [Full Text] [Related]
11. Prioritizing antiretrovirals for second-line therapy in resource-limited countries. Naidoo K AIDS Clin Care; 2008 May; 20(5):43. PubMed ID: 19230296 [No Abstract] [Full Text] [Related]
12. Antiretroviral therapy in resource-poor settings: scaling up inequalities? Egger M; Boulle A; Schechter M; Miotti P Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732 [No Abstract] [Full Text] [Related]
13. Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention. Gayle H; Lange JM Lancet; 2004 Jul 3-9; 364(9428):6-8. PubMed ID: 15234835 [No Abstract] [Full Text] [Related]
14. HIV in India--the challenges ahead. Steinbrook R N Engl J Med; 2007 Mar; 356(12):1197-201. PubMed ID: 17377154 [No Abstract] [Full Text] [Related]
15. The obligation to provide antiretroviral treatment in HIV prevention trials. Lo B; Padian N; Barnes M AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698 [TBL] [Abstract][Full Text] [Related]
16. COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings. Hetherington S Pediatr Infect Dis J; 2009 Jan; 28(1):41-2. PubMed ID: 19057455 [TBL] [Abstract][Full Text] [Related]
17. Patents versus patients? Antiretroviral therapy in India. Havlir DV; Hammer SM N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852 [No Abstract] [Full Text] [Related]
18. Rationing antiretroviral therapy in Africa--treating too few, too late. Ford N; Mills E; Calmy A N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900 [No Abstract] [Full Text] [Related]
19. Current world literature. Curr Opin HIV AIDS; 2010 May; 5(3):261-3. PubMed ID: 20539084 [No Abstract] [Full Text] [Related]
20. HIV/AIDS: the private sector is vital. England R Lancet; 2004 Sep 18-24; 364(9439):1033-4. PubMed ID: 15380956 [No Abstract] [Full Text] [Related] [Next] [New Search]